Forte Biosciences (FBRX) IV bid into data

Forte Biosciences (NASDAQ: FBRX) August call option implied volatility is at 230, September is at 275; compared to its 52-week range of 87 to 265 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis.

You May Also Be Interested In

• Oracle (ORCL) call put ratio 2.4 calls to 1 put with a focus on October 165 calls
• CoreWeave (CRWV) call put ratio 1.4 calls to 1 put
• Ishares U.S. Home Construction Etf (ITB) call put ratio 1 call to 32 puts with a focus on September puts